Drug development continues amid Guinea Ebola outbreak

03/26/2014 | Bloomberg

Ebola virus

Scientists are closing in on effective treatments for Ebola, a deadly zoonotic virus that causes fever, vomiting, diarrhea and internal and external hemorrhaging and has shown up in a recent outbreak in Guinea. Several treatments show promise, including the flu drug favipiravir, cancer drugs Gleevec and Tasigna, and several antibody cocktails in development. Human trials of a new Ebola drug were begun in January by Tekmira Pharmaceuticals, which has Defense Department funding for the research.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC